Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report

Urology Case Reports

Francisco Usubillaga¹  Julián Chavarriaga²  Marcela Urrego³  Lina Micolta⁴  Daniel Suso-Palau⁴  Josué Asprilla⁴ 

[1] Corresponding author. Carrera 38 A No. 5A 100, Cali, 76001, Colombia.;Division of Oncology, Clínica Imbanaco – Quirón Salud, Cali, Colombia;Division of Pathology, Clínica Imbanaco – Quirón Salud, Cali, Colombia;Division of Urology, Clínica Imbanaco – Quirón Salud, Cali, Colombia;

关键词: Metastasis;    Clear cell renal cell carcinoma;    Transplant;    Kidney;   

DOI  :  

来源: DOAJ

【 摘 要 】

Patients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the native kidney and discuss treatment options including targeted therapy, which appears to be the treatment of choice, even in the era of immunotherapy.

【 授权许可】

Unknown